Supplement structure/function v. disease claims distinction made in FDA proposed rules.
This article was originally published in The Tan Sheet
SUPPLEMENT STRUCTURE/FUNCTION v. DISEASE CLAIMS DISTINCTION MADE by FDA in proposed rules scheduled for publication in the Federal Register the week of April 27. The agency proposal establishes the criteria both for structure/function claims allowed under the Dietary Supplement Health & Education Act and disease claims, which are prohibited for supplements. The law allows, without FDA authorization, "claims that are truthful and not misleading about the effect of a dietary supplement on the structure or function of the body for maintenance of good health and nutrition," FDA said April 24.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC